← SynDRA
NUVISERTIB
SynDRA canonical compound SYN0038673 — structure-anchored drug synonym record
Clinical phase
Phase 1
Primary target(s)
PIM1 | PIM3
Mechanism of action
1,4,5-trisphosphate inhibitor
All known targets
PIM1
PIM3
Mechanisms of action (all sources)
1,4,5-trisphosphate inhibitor
Cross-references
PubChem CID:
66598080
ChEMBL:
CHEMBL3975308
DrugBank:
DB18109
TTD: D7Z1CR
Synonyms
TP-3654
SGI-9481
SGI9481
TP3654
TP 3654
UNII-EOB0N7BOY4
EOB0N7BOY4
2-((1r,4r)-4-((3-(3-(trifluoromethyl)phenyl)imidazo[1,2-b]pyridazin-6-yl)amino)cyclohexyl)propan-2-ol
SCHEMBL102560
CHEMBL3975308
SCHEMBL19986953
SCHEMBL20794171
SCHEMBL22421478
BDBM242374
BCP30070
EX-A1828
NSC805149
AKOS032960444
CS-6293
NSC-805149
SB17245
BS-15262
HY-101126
AK00792306
S6774
US9416132, 8-31
2-(4-((3-(3-(Trifluoromethyl)phenyl)imidazo(1,2-b)pyridazin-6-yl)amino)cyclohexyl)propan-2-ol
4-((3-(3-(Trifluoromethyl)phenyl)imidazo(1,2-b)pyridazin-6-yl)amino) -trans-cyclohexyl)propan-2-ol
Look up NUVISERTIB in the interactive SynDRA portal →